14th Feb 2022 16:16
14 February 2022
SourceBio International plc
("SourceBio", the "Company" or the "Group")
Director/PDMR Shareholding
SourceBio International plc ("the Company") has been notified that on 14 February 2022, Harwood Capital LLP transferred 568,460 ordinary shares of 0.15 pence each in the Company ("Ordinary Shares") to Limited Partners of Harwood Private Equity IV L.P. ("HPE4") in order to satisfy distributions, in the normal course of business.
Christopher Mills, Non-Executive Director of the Company is Chief Executive of Harwood Capital LLP.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||||
a)
| Name
|
Harwood Capital LLP as investment manager | ||||||
2
| Reason for the notification
| |||||||
a)
| Position/status
| Christopher Mills is a non-executive director of the issuer and Chief Executive of the investment manager | ||||||
b)
| Initial notification /Amendment
| Initial Notification | ||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||||
a)
| Name
| SourceBio International Plc | ||||||
b)
| LEI
| 213800KY4C9WU7WBW518
| ||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of £0.0015 each | ||||||
Identification code | GB00BKSB1674
| |||||||
| ||||||||
b)
| Nature of the transaction
| Transfer of shares
| ||||||
c) | Price(s) and volume(s) |
|
|
| ||||
d)
| Aggregated information
Volume Price |
N/A - single transaction | ||||||
e)
| Date of the transaction
| 14 February 2022 | ||||||
f)
| Place of the transaction
| Off market
| ||||||
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BKSB1674
Issuer Name
SOURCEBIO INTERNATIONAL PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Harwood Capital Management (Gibraltar) Limited
City of registered office (if applicable)
Gibraltar
Country of registered office (if applicable)
Gibraltar
Name | City of registered office | Country of registered office |
Harwood Capital LLP | London | United Kingdom |
4. Details of the shareholder
Name | City of registered office | Country of registered office |
Oryx International Growth Fund Limited | St Peter Port | Guernsey |
North Atlantic Smaller Companies Investment Trust plc | London | United Kindom |
Harwood Capital LLP | London | United Kingdom |
5. Date on which the threshold was crossed or reached
14-Feb-2022
6. Date on which Issuer notified
14-Feb-2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
Resulting situation on the date on which threshold was crossed or reached | 22.680000 | 0.000000 | 22.680000 | 16824766 |
Position of previous notification (if applicable) | 23.540000 | 0.000000 | 23.540000 | 17464284 |
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
GB00BKSB1674 | 1074766 | 1.450000 | ||
GB00BKSB1674 | 13250000 | 17.860000 | ||
GB00BKSB1674 | 2500000 | 3.370000 | ||
Sub Total 8.A | 16824766 | 22.680000% | ||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
Sub Total 8.B1 | ||||
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2 | |||||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
Christopher Harwood Bernard Mills | Oryx International Growth Fund Limited | 3.370000 | ||
Christopher Harwood Bernard Mills | North Atlantic Smaller Companies Investment Trust plc | 17.860000 | ||
Christopher Harwood Bernard Mills | Harwood Capital LLP | 1.450000 |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
12. Date of Completion
14-Feb-2022
13. Place Of Completion
Off market
Related Shares:
SBI.L